Follow Sushant Kumar
Follow Sushant Kumar
Make a free account and we’ll email you when they’re booked to speak, or their slides or recordings are posted.
Get an email when they’re booked to speak.
Sushant Kumar
Immunoadoptive Cell Therapy Pvt. Ltd. (ImmunoACT)
Head R&D
Dr. Sushant Kumar is the Head-R&D at ImmunoACT and contributed to India’s first and world’s most affordable CAR-T cell therapy, NexCAR19™. He leads the end-to-end development of CAR-T cell therapies including in vivo CAR-T therapies for cancers. He holds an MTech from IIT Guwahati, a PhD from IIT Bombay, and completed his postdoc training at the University of Pennsylvania, USA. He has authored more than 20 peer-reviewed publications in international journals, and has received several international recognitions, including the Young Investigator Award and international research grants, served on the Scientific Advisory Council of Uplifting Athletes, USA, and has been a guest editor and reviewer for several international journals.
1 talk
Speaking
2026
-
Nov 18–19
DIA India Annual Meeting 2026 Upcoming